Literature DB >> 10942

Residual effects of flunitrazepam.

A J Bond, M H Lader.   

Abstract

1 Twelve normal subjects were tested on a large battery of tests after a hypnotic dose of flunitrazepam(1 or 2 mg) and a placebo. Psychological tests were given 12 h after the drug and physiological tests 12, 15 and 18 h after the drug. 2 The tests included self-ratings of hypnotic effects and mood, the electroencephalogram, the auditory electroencephalographic evoked response, skin conductance, tapping, card-sorting and the symbol copying test. 3 Both doses of flunitrazepam were effective hypnotics according to the ratings, with an anxiolytic effect the following day. The EEG was significantly altered up to 18 h after the drug and the behavioural tests showed a motor impairment 12 h after drug administration. 4 Nearly all changes displayed linear dose-related trends.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 10942      PMCID: PMC1402512          DOI: 10.1111/j.1365-2125.1975.tb01569.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man.

Authors:  C KORNETSKY; T S VATES; E K KESSLER
Journal:  J Pharmacol Exp Ther       Date:  1959-09       Impact factor: 4.030

2.  The residual effects of N-desmethyldiazepam in patients.

Authors:  M Tansella; C Zimmermann-Tansella; M Lader
Journal:  Psychopharmacologia       Date:  1974

3.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

4.  Residual effects of hypnotics.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1972

5.  Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium.

Authors:  A Malpas; A J Rowan; C R Boyce; D F Scott
Journal:  Br Med J       Date:  1970-06-27
  5 in total
  34 in total

Review 1.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.

Authors:  G Bensimon; J Foret; D Warot; L Lacomblez; J F Thiercelin; P Simon
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Residual effects of lormetazepam on mood and performance in healthy elderly volunteers.

Authors:  J B Deijen; M L Heemstra; J F Orlebeke
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Residual effects of hypnotic drugs: evidence for individual differences on vigilance.

Authors:  A W Peck; R Adams; C Bye; R T Wilkinson
Journal:  Psychopharmacologia       Date:  1976-05-28

5.  Differences between light and sound sleepers in the residual effects of nitrazepam.

Authors:  A W Peck; C E Bye; R Claridge
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  The effect of ethanol on residual plasma methaqualone concentrations and behaviour in volunteers who have taken Mandrax.

Authors:  S Roden; P Harvey; M Mitchard
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

7.  Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man.

Authors:  A N Nicholson; B M Stone; C H Clarke
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

8.  Psychopharmacological effects of vinpocetine in normal healthy volunteers.

Authors:  Z Subhan; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  A comparison of the psychotropic profiles of tofisopam and diazepam.

Authors:  A Bond; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.